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It has been 8 years since our group introduced the
concept of a donor risk index (DRI), a composite mea-
sure of the risk of failure of deceased donor livers
offered for transplantation.1 The primary motivation
was to provide a quantitative tool to assist transplant
professionals in the evaluation of organ offers. Volk
et al.2 clearly demonstrated that physician intuition
about risk is often wrong. We felt that the DRI would
be an improvement over the intuitive assessment of
individual donor characteristics and could provide a
particular advantage for the simultaneous evaluation
of multiple risk factors when relative importance and
counteracting effects may be difficult to discern.
Later analyses of organs actually used for transplan-
tation revealed clear practice patterns in the transplant
community: higher risk organs as measured by the
DRI were being preferentially transplanted into lower
risk recipients. Moreover, contrary to the prevailing
opinions of the time, observations about the large
transplant survival benefit afforded to candidates with
high Model for End-Stage Liver Disease (MELD) scores,
even when they received high-DRI organs, led to
changes in the liver allocation policy to discourage
transplantation for candidates with low MELD scores.3
In 2009, the DRI was adapted for kidney donors.4
For the past several years, a normalized version
scaled from 0% to 100%, termed the kidney donor
profile index (KDPI), has been available to transplant
physicians and surgeons evaluating deceased donor
kidney offers on the electronic DonorNet notification
system.5 The new deceased donor kidney allocation
system, slated for implementation near the end of
2014, explicitly uses the KDPI as a component of the
allocation algorithm. To date, however, the liver DRI
has not been incorporated into electronic organ offer
notification or used explicitly as a component of organ
allocation policy.
It is clear that quantitative measures of donor qual-
ity such as the KDPI and the liver DRI are valued by
the transplant community. Are they perfect? Certainly
not. For example, the liver DRI does not include some
factors that are well known to influence outcomes but
are not universally available or collected (eg, steato-
sis). Even though such factors cannot be used in a
modified DRI per se, they can be, should be, and are
being used every day as additional inputs to the
decision-making process. Nobody ever said that the
DRI should be used in isolation. According to Feng
et al.,1 “quantitative assessment of the risk of donor
liver graft failure using a donor risk index is useful to
inform the process of organ acceptance.” It is not the
entirety of the process.
The liver DRI can, of course, be used for purposes
other than the evaluation of organ offers. In this issue
of Liver Transplantation, Mataya et al.6 report a
survey-based study of transplant providers and focus
on the use of the DRI in counseling liver transplant
candidates about donor risk. Unfortunately, the sur-
vey response rate (partial or complete survey comple-
tion) was only 37%, and the authors acknowledge
that this may have led to biased results. Nonetheless,
the results are interesting and raise important ques-
tions about the use and usefulness of the liver DRI.
Nearly two-thirds of the respondents were very
familiar with the liver DRI, and this suggests that the
dissemination of the concept has been substantial.
Approximately 1 in 6 now explicitly include the liver
DRI in their discussions with patients, and most of
those who do not discuss it as a composite measure
mention most or all of its components when they
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discuss risk with candidates. It would have been
interesting to learn what differentiates those physi-
cians who include the liver DRI in their discussions
from those who do not. Paradoxically, a majority of
the respondents reported the belief that the liver DRI
does not adequately describe the risk of graft failure
or that some factors render it potentially misleading,
yet nearly one-half (46%) believed that the inclusion
of the liver DRI in patient discussions would improve
shared decision making, and less than 25% believed
that its inclusion would worsen it. Although the calcu-
lation itself may be off-putting to some, other similarly
complex equation-based scores such as the MELD
score and the KDPI have been made widely available
and have been embraced. In liver transplantation, the
MELD score is now discussed regularly with patients
and families without undue reservations about scien-
tific complexity.
There are other questions about the liver DRI that
remain unanswered. We do not know what proportion
of transplant physicians and surgeons currently use
the liver DRI in organ acceptance decisions or would
do so if it were available on DonorNet. In their survey,
the authors did not inquire about the use of liver DRI
calculators, although examples are available online7
and as a downloadable smartphone application.8 The
liver DRI is like any other tool: you need to invest the
effort to learn how to use it effectively.
Finally, we do not know what our patients—those
really accepting the risk—want to know. Patient-
centered research has the potential to dramatically
improve our ability to provide helpful, meaningful, and
timely information to those who entrust their lives and
health to us. Carefully designed, scientifically sound
studies evaluating the role of tools such as the liver
DRI in these settings would go a long way to answering
the question.
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